Natesto

DRUG2 trials

Sponsors

University of Miami, Acerus Pharmaceuticals Corporation

Conditions

HypogonadismHypogonadism, Male

Phase 4

Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters

CompletedNCT03203681

University of MiamiHypogonadism, Male

Start: 2017-10-27End: 2020-06-01Updated: 2021-10-19

A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel

Acerus Pharmaceuticals CorporationHypogonadism

Start: 2021-07-01End: 2022-12-31Target: 218Updated: 2022-07-06

Related Papers

231 Natesto Effects on Reproductive Hormones and Semen Parameters: Results from an ongoing Single Center Investigator-initiated Phase IV Clinical Trial

The Journal of Sexual Medicine2019-03-291 citations